Literature DB >> 35836206

Correction: The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009-2014: a nationwide longitudinal study.

Tonje Teigland1,2, Jannicke Igland3,4, Grethe S Tell4, Johannes Haltbakk3, Marit Graue3, Anne-Siri Fismen3, Kåre I Birkeland5,6, Truls Østbye4,7, Mark Peyrot3,8, Marjolein M Iversen9.   

Abstract

Entities:  

Year:  2022        PMID: 35836206      PMCID: PMC9281115          DOI: 10.1186/s12902-022-01091-7

Source DB:  PubMed          Journal:  BMC Endocr Disord        ISSN: 1472-6823            Impact factor:   3.263


× No keyword cloud information.
Correction: BMC Endocr Disord 22, 159 (2022) https://doi.org/10.1186/s12902-022-01068-6 After publication of this article [1], it was brought to our attention that the Fig. 1 is incorrect, the correct Fig. 1 is shown below:
Fig. 1

Study population recruited from IPLOSa and linked to data from NorPDe, showing data from 2009. a IPLOS = the Norwegian Information System for the Nursing and Care Sector, b HCS = Home care service, c DM = Diabetes mellitus, pharmacologically treated, d GLD = Glucose lowering drugs, e NorPD = Norwegian Prescription Database. Prescriptions with ATC code A10A (insulins and analogues) is defined as insulin, prescriptions with ATC code A10B (blood glucose lowering drugs, exclusive insulins) is defined as non-insulin glucose lowering drugs (non-insulin GLD) and prescriptions with either ATC code A10A or A10B is defined as glucose lowering drugs (GLD)

Study population recruited from IPLOSa and linked to data from NorPDe, showing data from 2009. a IPLOS = the Norwegian Information System for the Nursing and Care Sector, b HCS = Home care service, c DM = Diabetes mellitus, pharmacologically treated, d GLD = Glucose lowering drugs, e NorPD = Norwegian Prescription Database. Prescriptions with ATC code A10A (insulins and analogues) is defined as insulin, prescriptions with ATC code A10B (blood glucose lowering drugs, exclusive insulins) is defined as non-insulin glucose lowering drugs (non-insulin GLD) and prescriptions with either ATC code A10A or A10B is defined as glucose lowering drugs (GLD) The original publication has been corrected.
  1 in total

1.  The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009-2014: a nationwide longitudinal study.

Authors:  Tonje Teigland; Jannicke Igland; Grethe S Tell; Johannes Haltbakk; Marit Graue; Anne-Siri Fismen; Kåre I Birkeland; Truls Østbye; Mark Peyrot; Marjolein M Iversen
Journal:  BMC Endocr Disord       Date:  2022-06-14       Impact factor: 3.263

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.